Glenna Meister

Glenna Meister has a strong background in biotechnology and protein engineering with experience in various roles and organizations. Glenna is currently working as a Principal Scientist at Arbor Biotechnologies since 2023. Prior to this, Glenna worked at Novartis Institutes for BioMedical Research (NIBR) from 2017 to 2023, where they held the positions of Principal Scientist II and Principal Scientist I. At NIBR, they led the Protein Engineering Lab and was responsible for designing, optimizing, and producing proteins for oncology drug discovery.

Before joining NIBR, Glenna worked at the Dana-Farber Cancer Institute from 2013 to 2017, where they held the positions of Scientist II, Scientist I, and Research Fellow. Their work at this institute involved creating Crispr/Cas9-methyltransferase fusion proteins for epigenetic regulation of gene expression in mammalian cells. Additionally, Glenna has experience as a Postdoctoral Fellow and Research Associate at the Wyss Institute for Biologically Inspired Engineering, Harvard University from 2010 to 2013, where they focused on engineering proteins to control molecular switches in biological signaling.

Glenna's academic journey started at Johns Hopkins University, where they completed their Ph.D. in Protein Engineering. Their thesis work involved creating site-specific DNA methyltransferases using directed evolution and rational design approaches.

Overall, Glenna Meister's work experience demonstrates their expertise in protein engineering, molecular biology, and oncology drug discovery.

Glenna Meister earned a Ph.D. in Chemical and Biomolecular Engineering from The Johns Hopkins University. Prior to that, they completed their undergraduate studies at the University of Illinois Urbana-Champaign, obtaining a B.S. in Chemical Engineering.